Platelet-rich plasma for the treatment of androgenetic alopecia - A randomized placebo-controlled pilot study

Not Applicable

• Conditions: L64; L65; Androgenic alopecia; Other nonscarring hair loss

• Registration Number: DRKS00019891
• Lead Sponsor: niv.-Klinik für Dermatologie und VenerologieMedizinische Universität Graz

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2019-10-03
• Study Start: 2019-12-09
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: Male
• Target Recruitment: 30

Inclusion Criteria

Male patients with AGA Norwood-Hamilton = 3
- Age 18 – 55 years
- Untreated androgenetic alopecia
- signed informed consent

Exclusion Criteria

- Patients with previously or ongoing treatment for AGA (Finasteride, Minoxidil)
- Condition after hair transplantation
- Malignancy, haematological disorders, thyroid dysfunction, malnutrition and other dermatological disorders contributing to hair loss

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Increase in hair density and hair thickness measured with the trichoscan

Secondary Outcome Measures

Name	Time	Method
Improved clinical appearance measured on the Norwood-Hamilton scale